Apyx Medical Corp Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2025-11-06: Disclosure Rule10b51Arr Adopted; Period 2025-01-01..2025-09-30; Value No.
- 2025-11-06: Disclosure Non Rule10b51Arr Adopted; Period 2025-01-01..2025-09-30; Value No.
- 2025-11-06: Disclosure Rule10b51Arr Terminated; Period 2025-01-01..2025-09-30; Value No.
- 2025-11-06: Disclosure Non Rule10b51Arr Terminated; Period 2025-01-01..2025-09-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2025-11-06 10-Q | Rule10b51Arr Adopted | 2025-01-01..2025-09-30 | No | |
| 2025-11-06 10-Q | Non Rule10b51Arr Adopted | 2025-01-01..2025-09-30 | No | |
| 2025-11-06 10-Q | Rule10b51Arr Terminated | 2025-01-01..2025-09-30 | No | |
| 2025-11-06 10-Q | Non Rule10b51Arr Terminated | 2025-01-01..2025-09-30 | No | |
| 2025-11-06 10-Q | Material Terms Of Trading Arrangement | 2025-01-01..2025-09-30 | ITEM 5. Other Information None. | |
| 2025-08-07 10-Q | Rule10b51Arr Adopted | 2025-01-01..2025-06-30 | No | |
| 2025-08-07 10-Q | Non Rule10b51Arr Adopted | 2025-01-01..2025-06-30 | No | |
| 2025-08-07 10-Q | Rule10b51Arr Terminated | 2025-01-01..2025-06-30 | No | |
| 2025-08-07 10-Q | Non Rule10b51Arr Terminated | 2025-01-01..2025-06-30 | No | |
| 2025-08-07 10-Q | Material Terms Of Trading Arrangement | 2025-01-01..2025-06-30 | ITEM 5. Other Information None . | |
| 2025-06-25 DEF 14A | Insider Trading Policies Proc Adopted | 2024-01-01..2024-12-31 | Yes | |
| 2025-06-25 DEF 14A | Pay versus Performance Table | 2024-01-01..2024-12-31 | Pay vs Performance This section is included to comply with the provisions of Item 402(v) of Regulation S-K. For a more comprehensive analysis of our compensation philosophy please see the General Compensation Philosophy section of this filing. In the table and footnotes below, “PEO” refers to our pr… | |
| 2025-06-25 DEF 14A | Named Executive Officers Footnote | 2024-01-01..2024-12-31 | Reflects average compensation amounts for our non-PEO named executive officers for the respective years shown. Moshe Citronowicz, Todd Hornsby, Matthew Hill and Shawn Roman are the non-PEO named executive officers for the 2024 year presented. | |
| 2025-06-25 DEF 14A | Named Executive Officers Footnote | 2023-01-01..2023-12-31 | Moshe Citronowicz, Todd Hornsby, Matthew Hill and Tara Semb are the non-PEO named executive officers for the 2023 year presented. | |
| 2025-06-25 DEF 14A | Named Executive Officers Footnote | 2022-01-01..2022-12-31 | Moshe Citronowicz, Todd Hornsby and Tara Semb are the non-PEO named executive officers for the 2022 year presented. | |
| 2025-06-25 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2024-01-01..2024-12-31 | PEO Non-PEO NEOs 2024 2023 2022 2024 2023 2022 Summary compensation table total compensation $ 975,971 $ 1,261,470 $ 2,170,236 $ 675,407 $ 769,679 $ 974,614 Grant date fair value of awards granted during the year (453,273 ) (448,335 ) (1,664,793 ) (173,475 ) (164,820 ) (612,023 ) Fair value of award… | |
| 2025-06-25 DEF 14A | Adjustment To PEO Compensation Footnote | 2024-01-01..2024-12-31 | PEO Non-PEO NEOs 2024 2023 2022 2024 2023 2022 Summary compensation table total compensation $ 975,971 $ 1,261,470 $ 2,170,236 $ 675,407 $ 769,679 $ 974,614 Grant date fair value of awards granted during the year (453,273 ) (448,335 ) (1,664,793 ) (173,475 ) (164,820 ) (612,023 ) Fair value of award… | |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | -$453.27K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | -$448.33K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$1.66M |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$173.47K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$164.82K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$612.02K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $270.06K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $493.29K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $255.11K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $54.73K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $116.39K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $93.79K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | -$211.41K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $65.73K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$1.16M |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$26.54K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $15.51K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$425.08K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | -$72.12K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $41.33K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | -$257.93K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$45.20K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $660.00 |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | -$86.47K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $0.00 |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $0.00 |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $0.00 |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | $22.14K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | $8.19K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $0.00 |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo | 2024-01-01..2024-12-31 | $0.00 |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo | 2023-01-01..2023-12-31 | $0.00 |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: Peo | 2022-01-01..2022-12-31 | $0.00 |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-01-01..2024-12-31 | -$16.92K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-01-01..2023-12-31 | -$11.20K |
| 2025-06-25 DEF 14A | Adjustment To Compensation | AdjToComp: FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYr; ExecutiveCategory: NonPeoNeo | 2022-01-01..2022-12-31 | $0.00 |
| 2025-06-25 DEF 14A | Compensation Actually Paid Vs Total Shareholder Return | 2024-01-01..2024-12-31 | The following table presents a comparison of our actual compensation paid to NEOs versus our total stockholder return, net losses: (in thousands except per share data) 2024 2023 2024 vs 2023 Change 2022 2023 vs 2022 Change Total stockholder return (change in stock price) $ 1.58 $ 2.62 (39.7 )% $ 2.3… | |
| 2025-06-25 DEF 14A | Compensation Actually Paid Vs Net Income | 2024-01-01..2024-12-31 | The following table presents a comparison of our actual compensation paid to NEOs versus our total stockholder return, net losses: (in thousands except per share data) 2024 2023 2024 vs 2023 Change 2022 2023 vs 2022 Change Total stockholder return (change in stock price) $ 1.58 $ 2.62 (39.7 )% $ 2.3… | |
| 2025-05-08 10-Q | Rule10b51Arr Adopted | 2025-01-01..2025-03-31 | No | |
| 2025-05-08 10-Q | Non Rule10b51Arr Adopted | 2025-01-01..2025-03-31 | No | |
| 2025-05-08 10-Q | Rule10b51Arr Terminated | 2025-01-01..2025-03-31 | No | |
| 2025-05-08 10-Q | Non Rule10b51Arr Terminated | 2025-01-01..2025-03-31 | No | |
| 2025-05-08 10-Q | Material Terms Of Trading Arrangement | 2025-01-01..2025-03-31 | ITEM 5. Other Information None . | |
| 2025-03-13 10-K | Rule10b51Arr Adopted | 2024-01-01..2024-12-31 | No | |
| 2025-03-13 10-K | Non Rule10b51Arr Adopted | 2024-01-01..2024-12-31 | No | |
| 2025-03-13 10-K | Rule10b51Arr Terminated | 2024-01-01..2024-12-31 | No | |
| 2025-03-13 10-K | Non Rule10b51Arr Terminated | 2024-01-01..2024-12-31 | No | |
| 2025-03-13 10-K | Material Terms Of Trading Arrangement | 2024-01-01..2024-12-31 | ITEM 9B. Other Information None. |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |